EUVIMEDEUVIMED entdecken
Crossref

Submucosal fibrosis in large colorectal serrated lesions in cases receiving endoscopic submucosal dissection

Y Tomita, N Yoshida, E Manriquez-Alegria, R Kobayashi, K Inoue, O Dohi, L Cardoso, K Uchiyama, T Takagi

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S210

DOI: 10.1055/s-0046-1820985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von Y Tomita und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Colorectal serrated lesions (CSLs) are increasingly recognized as important precursors of colorectal cancer, accounting for up to a quarter of cases. Recent advances include the 2019 WHO classification, which categorizes CSLs into sessile serrated lesions (SSL), SSL with dysplasia (SSLD), traditional serrated adenomas (TSA), and unclassified serrated adenomas. Although piecemeal resection is widely used, larger CSLs may harbor unexpected dysplasia and carry a higher risk of metachronous neoplasia, underscoring the importance of achieving accurate histological evaluation. Endoscopic submucosal dissection (ESD) enables en bloc resection and precise pathological assessment, but its technical difficulty and risk profile are influenced by factors such as lesion size, location, and submucosal fibrosis. This study aimed to clarify the association between CSLs and submucosal fibrosis, and to determine how fibrosis affects therapeutic outcomes in colorectal ESD.

Methods

This retrospective cohort study reviewed consecutive colorectal ESD procedures performed at Kyoto Prefectural University of Medicine from January 2020 to November 2024. To align with the 2019 WHO classification, only lesions measuring≥20 mm was included. Indications followed Japanese ESD guidelines, with serrated lesions treated when SSLs were≥30 mm or when lesions≥20 mm were suspected to be SSLD or TSA based on magnified endoscopic evaluation. Lesions were classified histologically as CSLs—including SSL, TSA, SSLD, and unclassified serrated adenomas—or as adenomas/T1 cancers. Data on patient and lesion characteristics, fibrosis status, and therapeutic outcomes were collected. Submucosal fibrosis was graded endoscopically. ESD outcomes included procedure time, en bloc and R0 resection, and adverse events such as perforation or delayed bleeding. The primary outcome was the frequency of any or severe fibrosis in CSLs compared with adenomas/T1 cancers. Logistic regression analyses identified predictors of fibrosis, severe fibrosis, and prolonged procedure time (>90 min), with lesion size categorized as

Zitieren

APA

Tomita, Y., Yoshida, N., Manriquez-Alegria, E., Kobayashi, R., Inoue, K., Dohi, O., Cardoso, L., Uchiyama, K., & Takagi, T. (2026). Submucosal fibrosis in large colorectal serrated lesions in cases receiving endoscopic submucosal dissection. Endoscopy, 58(S 03 S 03), S210. https://doi.org/10.1055/s-0046-1820985

Vancouver

Tomita Y, Yoshida N, Manriquez-Alegria E, Kobayashi R, Inoue K, Dohi O, et al. Submucosal fibrosis in large colorectal serrated lesions in cases receiving endoscopic submucosal dissection. Endoscopy. 2026;58(S 03 S 03):S210. doi:10.1055/s-0046-1820985

BibTeX
@article{Tomita2026,
  author = {Tomita, Y and Yoshida, N and Manriquez-Alegria, E and Kobayashi, R and Inoue, K and Dohi, O and Cardoso, L and Uchiyama, K and Takagi, T},
  title = {Submucosal fibrosis in large colorectal serrated lesions in cases receiving endoscopic submucosal dissection},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S210},
  doi = {10.1055/s-0046-1820985}
}
Kostenlos starten →